Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system

Gene Therapy volume 6, pages 715–728 (1999)Cite this article

Abstract

Lentiviruses infect both dividing and nondividing cells. In this study we characterized a lentiviral vector system consisting of a packaging vector (pHP) and a transducing vector (pTV) derived from a recombinant human immunodeficiency virus type 1 (HIV-1). In pHP, the long terminal repeats (LTRs), the 5′ untranslated leader and portions of the env and nef genes were deleted. The leader sequence of pHP was substituted with a modified Rous sarcoma virus (RSV) 59 bp leader containing a mutated RSV gag AUG and a functional 5′ splice site. The pHP construct was found to direct Gag-Pol synthesis as efficiently as wild-type HIV-1. The pTV construct contains sequences required for RNA packaging, reverse transcription and integration, but lacks viral genes. Co-transfection of pHP, pTV and a vesicular stomatitis virus G (VSV-G) envelope plasmid produced vectors at titers of 105–106 transducing units per milliliter in 48 h. Replication-competent virus (RCV) was not detected when deletions were made in the env gene in pHP. The ability of this vector system to transduce dividing and nondividing cell in vitro and in vivo was also demonstrated. Compared with a Moloney murine leukemia virus (MLV) vector, the HP/TV vectors transduced human muscle-, kidney-, liver-derived cell lines and CD34+ primary hematopoietic progenitor cells more efficiently. Although the levels of the pTV transgene expression were high soon after transduction, the expression tended to decrease with time due either to the loss of proviral DNA or to the inactivation of promoter activity, which was found to be cell type-dependent. Analyses of extrachromosomal DNA showed that the unintegrated proviral DNA of lentiviral vectors survived much longer than that of the retroviral vectors. We demonstrate that the HP/TV vector is capable of high efficiency transduction and that long-term expression of lentiviral vectors is dependent on target cell type, the internal promoter and the transgene itself in the transducing vector.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Gordon EM, Anderson WF . Gene therapy using retroviral vectors Curr Opin Biotechnol 1994 5: 611–616

    Article  CAS  Google Scholar 

  2. Miller AD, Miller DG, Garcia JV, Lynch CM . Use of retroviral vectors for gene transfer and expression Meth Enzymol 1993 217: 581–599

    Article  CAS  Google Scholar 

  3. Russell D, Miller AD . Foamy virus vector J Virol 1996 70: 217–222

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Verma IM, Somia N . Gene therapy – promises, problems and prospects Nature 1997 389: 239–242

    Article  CAS  Google Scholar 

  5. Poeschla EM, Wong-Staal F, Looney DJ . Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors Nature Med 1998 4: 354–357

    Article  CAS  Google Scholar 

  6. Burns JC et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to a very high titer and efficient gene transfer into mammalian and nonmammalian cells Proc Natl Acad Sci USA 1993 90: 8033–8037

    Article  CAS  Google Scholar 

  7. Shimada T, Fujii H, Mitsuya H, Nienhuis AW . Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector J Clin Invest 1991 88: 1043–1047

    Article  CAS  Google Scholar 

  8. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272: 263–267

    Article  CAS  Google Scholar 

  9. Poeschla E, Corbeau P, Wong-Staal F . Development of HIV vectors for anti-HIV gene therapy Proc Natl Acad Sci USA 1996 93: 11395–11399

    Article  CAS  Google Scholar 

  10. Chang L-J, Zhang C . Infection and replication of Tat-minus human immunodeficiency viruses: genetic analyses of LTR and tat mutants in primary and long-term human lymphoid cells Virology 1995 211: 157–169

    Article  CAS  Google Scholar 

  11. Chang L-J, McNulty E, Martin M . Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms J Virol 1993 67: 743–752

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Steffy K, Wong-Staal F . Genetic regulation of human immunodeficiency virus Microb Rev 1991 55: 193–205

    CAS  Google Scholar 

  13. Zufferey R et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 1997 15: 871–875

    Article  CAS  Google Scholar 

  14. Robinson D, Elliott JF, Chang L-J . Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is upregulated by HIV-1 Tat Gene Therapy 1995 2: 269–278

    CAS  PubMed  Google Scholar 

  15. Stevenson M et al. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products J Virol 1990 64: 2421–2425

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Sakai H et al. Integration is essential for efficient gene expression of human immunodeficiency virus type 1 J Virol 1993 67: 1169–1174

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Boshart M et al. A very strong enhancer is located upstream of an immediate–early gene of human cytomegalovirus Cell 1985 41: 521–530

    Article  CAS  Google Scholar 

  18. Baskar JF et al. The enhancer domain of the human cytomegalovirus major immediate–early promoter determines cell type-specific expression in transgenic mice J Virol 1996 70: 3207–3214

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Xia H, Fitzgerald J, Bredt DS, Forsayeth JR . Detection of mycoplasma infection of mammalian cells BioTechniques 1997 22: 934–936

    Article  CAS  Google Scholar 

  20. Chang LJ, Stoltzfus CM . Cloning and nucleotide sequences of cDNA spanning the splice junctions of Rous sarcoma virus mRNAs J Virol 1985 53: 969–972

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Ure DR, Campenot RB, Acheson A . Cholinergic differentiation of rat sympathetic neurons in culture: effects of factors applied to distal neurites Dev Biol 1992 154: 388–395

    Article  CAS  Google Scholar 

  22. Kimpton J, Emerman M . Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene J Virol 1992 66: 2232–2239

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Motmans K, Thirion S, Raus J, Vandevyver C . Isolation and quantification of episomal expression vectors in human T cells BioTechniques 1997 23: 1044–1046

    Article  CAS  Google Scholar 

  24. Maniatis T, Fritsch EF, Sambrook J . Molecular Cloning: a Laboratory Manual Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Genetics and Microbiology, Gene Therapy Center, University of Florida Brain Institute, University of Florida, Gainesville, FL, USA

    L-J Chang, V Urlacher, T Iwakuma & Y Cui

  2. Department of Oncology, University of Florida, Gainesville, FL, USA

    J Zucali

Authors
  1. L-J Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V Urlacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Iwakuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Zucali
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, LJ., Urlacher, V., Iwakuma, T. et al. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther 6, 715–728 (1999). https://doi.org/10.1038/sj.gt.3300895

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300895

Keywords

This article is cited by

Search

Advanced search

Quick links